Summit Global Investments’s Boston Scientific BSX Stock Holding History

Summit Global Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,980	Closed	-$475K	–	491
2025 Q4	$475K	Sell	4,980 -13,768	-73%	-$1.35M	0.03%	328
2025 Q3	$1.83M	Sell	18,748 -629	-3%	-$65.1K	0.11%	111
2025 Q2	$2.08M	Buy	19,377 +300	+2%	+$30.4K	0.12%	113
2025 Q1	$1.93M	Buy	+19,077	New	+$1.92M	0.14%	89

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Summit Global Investments's BSX Position: Q1 2026 in Review

Summit Global Investments sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 4,980 shares — an estimated $475K sold.

Summit Global Investments first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $2.08M in Q2 2025. 1,668 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Summit Global Investments reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Summit Global Investments sold 4,980 Boston Scientific shares in Q1 2026, an estimated $475K.
Summit Global Investments first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
Summit Global Investments's Boston Scientific position peaked at $2.08M in Q2 2025.
1,668 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.